FDA product code QKA: Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
QKA is the FDA product code for temporarily-placed urethral opening system for symptoms of benign prostatic hyperplasia. It is a Class II device, regulated under 21 CFR 876.5510 and reviewed by the Gastroenterology and Urology panel. FDA has cleared 3 510(k) submissions under QKA, 2 in the last five years, from 2 different applicants. The average 510(k) review took 112 days (median 119); 90 days on average over the last three years. 1 De Novo request was granted under it.
Definition
A system intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.
Classification
| Field | Value |
|---|---|
| Device name | Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia |
| Device class | Class II |
| Regulation | 21 CFR 876.5510 |
| Review panel | GU — Gastroenterology and Urology |
| Medical specialty | Gastroenterology, Urology |
| Premarket route | 510(k) |
510(k) clearances per year for QKA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2021 | 1 | 157 |
| 2026 | 2 | 90 |
Compare with all 510(k) review times · Search every QKA clearance
Top QKA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Prodeon Medical, Inc. | 2 | 2026-06-22 |
| Medi-Tate , Ltd. | 1 | 2021-06-25 |
Most recent QKA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K261342 | Prodeon Medical, Inc. | Urocross Expander System (UES-2018-C1) | 2026-06-22 | 60 |
| K253525 | Prodeon Medical, Inc. | Urocross Expander System (Model Numbers ES2018 and ES3025) | 2026-03-12 | 119 |
| K210138 | Medi-Tate , Ltd. | iTind System | 2021-06-25 | 157 |
Recalls for QKA devices
FDA recall records list no recalls for product code QKA.
Frequently asked questions
What is FDA product code QKA?
QKA is the FDA product code for temporarily-placed urethral opening system for symptoms of benign prostatic hyperplasia. It is a Class II device, regulated under 21 CFR 876.5510 and reviewed by the Gastroenterology and Urology panel.
What device class is QKA?
Class II, regulation 21 CFR 876.5510. Typical premarket route: 510(k).
How long does a 510(k) take for product code QKA?
Across 3 cleared submissions the average was 112 days from receipt to decision (median 119).
Which companies have the most QKA clearances?
Prodeon Medical, Inc. (2); Medi-Tate , Ltd. (1).
Next steps
- Run an FDA pathway report with predicate devices for product code QKA
- Run a recall and safety report across every QKA manufacturer
- Watch product code QKA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Gastroenterology and Urology product codes · FDA product code lookup · 510(k) database search · 510(k) review times